|
|
???tair.name??? >
???browser.page.title.author???
|
"cw lin"???jsp.browse.items-by-author.description???
Showing items 6-15 of 76 (8 Page(s) Totally)
1 2 3 4 5 6 7 8 > >>
View [10|25|50] records per page
| 中山醫學大學 |
2017-03 |
Combinations of SERPINB5 gene polymorphisms and environmental factors are associated with oral cancer risks
|
HT, Tsai; MJ, Hsieh; CW, Lin; SC, Su; NF, Miao; SF, Yang; HC, Huang; FC, Lai; YF, Liu |
| 中山醫學大學 |
2016-10 |
Functional genetic variant in the Kozak sequence of WW domain-containing oxidoreductase (WWOX) gene is associated with oral cancer risk
|
HL, Cheng; YF, Liu; CW, Su; SC, Su; MK, Chen; SF, Yang; CW, Lin |
| 中山醫學大學 |
2016-04-27 |
Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis.
|
CW, Lin; WE, Yang; WJ, Lee; KT, Hua; FK, Hsieh; Hsiao, M; CC, Chen; JM, Chow; MK, Chen; SF, Yang; MH, Chien |
| 中山醫學大學 |
2016-04-19 |
Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation.
|
CM, Yeh; CW, Lin; JS, Yang; WE, Yang; SC, Su; SF, Yang |
| 中山醫學大學 |
2016-03-31 |
Hispolon suppresses migration and invasion of human nasopharyngeal carcinoma cells by inhibiting the urokinase-plasminogen activator through modulation of the Akt signaling pathway.
|
HY, Ho; YC, Ho; MJ, Hsieh; SF, Yang; CY, Chuang; CW, Lin; CH, Hsin |
| 中山醫學大學 |
2016-03-31 |
Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma.
|
WE, Yang; CC, Ho; SF, Yang; SH, Lin; KT, Yeh; CW, Lin; MK, Chen |
| 中山醫學大學 |
2016-03-01 |
Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways.
|
HL, Cheng;CW, Lin;JS, Yang;MJ, Hsieh;SF, Yang;KH, Lu |
| 中山醫學大學 |
2016-02-26 |
Resveratrol suppresses myofibroblast activity of human buccal mucosal fibroblasts through the epigenetic inhibition of ZEB1 expression.
|
YC, Chang;CW, Lin;CC, Yu;BY, Wang;YH, Huang;YC, Hsieh;YL, Kuo;WW, Chang |
| 中山醫學大學 |
2016-01-11 |
Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.
|
JS, Yang;CW, Lin;SC, Su;SF, Yang |
| 中山醫學大學 |
2015-12-14 |
The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies.
|
SC, Su; CW, Lin; WE, Yang; WL, Fan; SF, Yang |
Showing items 6-15 of 76 (8 Page(s) Totally)
1 2 3 4 5 6 7 8 > >>
View [10|25|50] records per page
|
